Equasens Société anonyme

ENXTPA:EQS Voorraadrapport

Marktkapitalisatie: €757.6m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Equasens Société anonyme Toekomstige groei

Future criteriumcontroles 1/6

Equasens Société anonyme zal naar verwachting groeien in winst en omzet met respectievelijk 6.3% en 5.1% per jaar. De winst per aandeel zal naar verwachting groeien met 6.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 18% zijn.

Belangrijke informatie

6.3%

Groei van de winst

6.3%

Groei van de winst per aandeel

Healthcare Services winstgroei25.7%
Inkomstengroei5.1%
Toekomstig rendement op eigen vermogen18.0%
Dekking van analisten

Low

Laatst bijgewerkt01 Oct 2024

Recente toekomstige groei-updates

Recent updates

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Sep 28
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Jul 15
Equasens Société anonyme's (EPA:EQS) Intrinsic Value Is Potentially 75% Above Its Share Price

Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Jun 22
Equasens Société anonyme's (EPA:EQS) Upcoming Dividend Will Be Larger Than Last Year's

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Jun 07
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

Apr 03
Equasens Société anonyme (EPA:EQS) Is Aiming To Keep Up Its Impressive Returns

At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Mar 08
At €51.10, Is It Time To Put Equasens Société anonyme (EPA:EQS) On Your Watch List?

Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Feb 14
Some Confidence Is Lacking In Equasens Société anonyme's (EPA:EQS) P/E

Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 27
Estimating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

Nov 29
Should You Investigate Equasens Société anonyme (EPA:EQS) At €59.70?

These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

Oct 28
These 4 Measures Indicate That Equasens Société anonyme (EPA:EQS) Is Using Debt Safely

A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Sep 27
A Look At The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Aug 05
Should You Think About Buying Equasens Société anonyme (EPA:EQS) Now?

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Jun 11
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.15

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 22
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

May 08
Equasens Société anonyme's (EPA:EQS) Shareholders Will Receive A Bigger Dividend Than Last Year

What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Apr 04
What Does Equasens Société anonyme's (EPA:EQS) Share Price Indicate?

Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Feb 13
Equasens Société anonyme (EPA:EQS) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

Jan 26
Calculating The Intrinsic Value Of Equasens Société anonyme (EPA:EQS)

At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Dec 21
At €71.60, Is Equasens Société anonyme (EPA:EQS) Worth Looking At Closely?

Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Dec 07
Should You Be Adding Equasens Société anonyme (EPA:EQS) To Your Watchlist Today?

Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Nov 12
Here's What's Concerning About Equasens Société anonyme's (EPA:EQS) Returns On Capital

Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Oct 27
Is Equasens Société anonyme (EPA:EQS) Trading At A 26% Discount?

Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

Oct 12
Is Equasens Société anonyme (EPA:EQS) Using Too Much Debt?

When Should You Buy Equasens Société anonyme (EPA:EQS)?

Sep 09
When Should You Buy Equasens Société anonyme (EPA:EQS)?

With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Aug 24
With EPS Growth And More, Equasens Société anonyme (EPA:EQS) Makes An Interesting Case

Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Jul 28
Equasens Société anonyme (EPA:EQS) Might Be Having Difficulty Using Its Capital Effectively

Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Jun 10
Equasens Société anonyme (EPA:EQS) Is Increasing Its Dividend To €1.05

Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

May 27
Pharmagest Interactive (EPA:PHA) Has Announced That It Will Be Increasing Its Dividend To €1.05

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

May 22
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Apr 25
Here's What Pharmagest Interactive's (EPA:PHA) Strong Returns On Capital Mean

Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Feb 23
Are Investors Undervaluing Pharmagest Interactive SA (EPA:PHA) By 28%?

Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Feb 09
Here's Why I Think Pharmagest Interactive (EPA:PHA) Might Deserve Your Attention Today

Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Jan 25
Is Pharmagest Interactive SA (EPA:PHA) Potentially Undervalued?

Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Jan 06
Many Would Be Envious Of Pharmagest Interactive's (EPA:PHA) Excellent Returns On Capital

Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Nov 14
Pharmagest Interactive (EPA:PHA) Could Easily Take On More Debt

Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Oct 30
Is There An Opportunity With Pharmagest Interactive SA's (EPA:PHA) 20% Undervaluation?

Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Sep 28
Is Now The Time To Put Pharmagest Interactive (EPA:PHA) On Your Watchlist?

Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Jul 18
Is Pharmagest Interactive SA (EPA:PHA) Trading At A 20% Discount?

Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Jun 24
Pharmagest Interactive (EPA:PHA) Will Want To Turn Around Its Return Trends

Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Apr 08
Does Pharmagest Interactive (EPA:PHA) Deserve A Spot On Your Watchlist?

Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Mar 24
Pharmagest Interactive SA (EPA:PHA) Is An Attractive Dividend Stock - Here's Why

Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Mar 03
Pharmagest Interactive SA's (EPA:PHA) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Feb 09
Our Take On The Returns On Capital At Pharmagest Interactive (EPA:PHA)

Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

Jan 12
Shareholders of Pharmagest Interactive (EPA:PHA) Must Be Delighted With Their 500% Total Return

What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Dec 15
What To Know Before Buying Pharmagest Interactive SA (EPA:PHA) For Its Dividend

Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?

Dec 01
Are Strong Financial Prospects The Force That Is Driving The Momentum In Pharmagest Interactive SA's EPA:PHA) Stock?

Winst- en omzetgroeiprognoses

ENXTPA:EQS - Toekomstschattingen van analisten en financiële gegevens uit het verleden (EUR Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20262545557704
12/31/20252405052654
12/31/20242234445584
12/31/2023220473958N/A
6/30/2023223485971N/A
3/31/2023219475364N/A
12/31/2022214464757N/A
6/30/2022203424251N/A
3/31/2022198414049N/A
12/31/2021193393748N/A
9/30/2021190373851N/A
6/30/2021188353954N/A
3/31/2021180333351N/A
12/31/2020172312847N/A
9/30/2020166292241N/A
6/30/2020160271735N/A
3/31/2020159272038N/A
12/31/2019159272441N/A
9/30/2019156272338N/A
6/30/2019153262136N/A
3/31/2019151262033N/A
12/31/2018148251829N/A
9/30/2018144252131N/A
6/30/2018139242433N/A
3/31/2018134242230N/A
12/31/2017130231927N/A
9/30/201712922N/A26N/A
6/30/201712821N/A26N/A
3/31/201712821N/A24N/A
12/31/201612821N/A23N/A
9/30/201612520N/A22N/A
6/30/201612120N/A22N/A
3/31/201611719N/A21N/A
12/31/201511319N/A20N/A
9/30/201511318N/A20N/A
6/30/201511218N/A21N/A
3/31/201511317N/A19N/A
12/31/201411517N/A17N/A
9/30/201411417N/A19N/A
6/30/201411316N/A21N/A
3/31/201411316N/A17N/A
12/31/201311316N/A12N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachte winstgroei EQS ( 6.3% per jaar) ligt boven de spaarquote ( 1.2% ).

Winst versus markt: De winst van EQS ( 6.3% per jaar) zal naar verwachting langzamer groeien dan de markt French ( 12.3% per jaar).

Hoge groeiwinsten: De winst van EQS zal naar verwachting groeien, maar niet aanzienlijk.

Omzet versus markt: De omzet van EQS ( 5.1% per jaar) zal naar verwachting langzamer groeien dan de markt French ( 5.7% per jaar).

Hoge groei-inkomsten: De omzet van EQS ( 5.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen EQS zal naar verwachting over 3 jaar laag zijn ( 18 %).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y